Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 660,000 | 670,858 | 715,110 | 778,032 | 662,000 |
| Cost of Goods | 331,000 | 316,091 | 330,488 | 362,421 | 316,000 |
| Gross Profit | 329,000 | 353,768 | 384,622 | 415,611 | 346,000 |
| Operating Expenses | 175,000 | 344,186 | 260,335 | 252,480 | 256,000 |
| Operating Income | 155,000 | 11,673 | 124,775 | 163,553 | 89,000 |
| Interest Expense | 4,000 | 3,951 | 2,890 | 3,159 | 3,000 |
| Other Income | 34,000 | 16,570 | 8,630 | 10,800 | 14,000 |
| Pre-tax Income | 185,000 | 24,292 | 130,515 | 171,194 | 100,000 |
| Income Tax | 35,000 | 19,184 | 35,542 | 37,274 | 23,000 |
| Net Income Continuous | 150,000 | 5,108 | 94,972 | 133,920 | 77,000 |
| Net Income | $150,000 | $5,108 | $94,972 | $133,920 | $77,000 |
| EPS Basic Total Ops | 0.18 | 0.01 | 0.11 | 0.16 | 0.09 |
| EPS Basic Continuous Ops | 0.18 | 0.01 | 0.11 | 0.16 | 0.09 |
| EPS Diluted Total Ops | 0.18 | 0.01 | 0.11 | 0.16 | 0.09 |
| EPS Diluted Continuous Ops | 0.18 | 0.01 | 0.11 | 0.16 | 0.09 |
| EBITDA(a) | $193,000 | $47,673 | $164,260 | $204,068 | $129,000 |